BHC
Price
$5.24
Change
-$0.43 (-7.58%)
Updated
Apr 4, 11:06 AM (EDT)
Capitalization
3.86B
26 days until earnings call
SUPN
Price
$32.49
Change
-$0.33 (-1.01%)
Updated
Apr 3 closing price
Capitalization
1.84B
39 days until earnings call
Ad is loading...

BHC vs SUPN

Header iconBHC vs SUPN Comparison
Open Charts BHC vs SUPNBanner chart's image
Bausch Health Companies
Price$5.24
Change-$0.43 (-7.58%)
Volume$5.98K
Capitalization3.86B
Supernus Pharmaceuticals
Price$32.49
Change-$0.33 (-1.01%)
Volume$542.62K
Capitalization1.84B
BHC vs SUPN Comparison Chart
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. SUPN commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Buy and SUPN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BHC: $5.67 vs. SUPN: $32.49)
Brand notoriety: BHC: Notable vs. SUPN: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 89% vs. SUPN: 86%
Market capitalization -- BHC: $3.86B vs. SUPN: $1.84B
BHC [@Pharmaceuticals: Other] is valued at $3.86B. SUPN’s [@Pharmaceuticals: Other] market capitalization is $1.84B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 1 FA rating(s) are green whileSUPN’s FA Score has 0 green FA rating(s).

  • BHC’s FA Score: 1 green, 4 red.
  • SUPN’s FA Score: 0 green, 5 red.
According to our system of comparison, SUPN is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 4 TA indicator(s) are bullish while SUPN’s TA Score has 4 bullish TA indicator(s).

  • BHC’s TA Score: 4 bullish, 7 bearish.
  • SUPN’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SUPN is a better buy in the short-term than BHC.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а -16.00% price change this week, while SUPN (@Pharmaceuticals: Other) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.00%. For the same industry, the average monthly price growth was -2.21%, and the average quarterly price growth was -10.30%.

Reported Earning Dates

BHC is expected to report earnings on Apr 30, 2025.

SUPN is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BHC($3.86B) has a higher market cap than SUPN($1.84B). SUPN has higher P/E ratio than BHC: SUPN (1677.00) vs BHC (13.39). SUPN YTD gains are higher at: -10.149 vs. BHC (-29.653). BHC has higher annual earnings (EBITDA): 2.2B vs. SUPN (90M). BHC has more cash in the bank: 947M vs. SUPN (255M). SUPN has less debt than BHC: SUPN (41.5M) vs BHC (22.4B). BHC has higher revenues than SUPN: BHC (8.76B) vs SUPN (608M).
BHCSUPNBHC / SUPN
Capitalization3.86B1.84B210%
EBITDA2.2B90M2,447%
Gain YTD-29.653-10.149292%
P/E Ratio13.391677.001%
Revenue8.76B608M1,440%
Total Cash947M255M371%
Total Debt22.4B41.5M53,976%
FUNDAMENTALS RATINGS
BHC vs SUPN: Fundamental Ratings
BHC
SUPN
OUTLOOK RATING
1..100
698
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
72
Overvalued
PROFIT vs RISK RATING
1..100
10040
SMR RATING
1..100
10078
PRICE GROWTH RATING
1..100
8655
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BHC's Valuation (32) in the Pharmaceuticals Other industry is somewhat better than the same rating for SUPN (72). This means that BHC’s stock grew somewhat faster than SUPN’s over the last 12 months.

SUPN's Profit vs Risk Rating (40) in the Pharmaceuticals Other industry is somewhat better than the same rating for BHC (100). This means that SUPN’s stock grew somewhat faster than BHC’s over the last 12 months.

SUPN's SMR Rating (78) in the Pharmaceuticals Other industry is in the same range as BHC (100). This means that SUPN’s stock grew similarly to BHC’s over the last 12 months.

SUPN's Price Growth Rating (55) in the Pharmaceuticals Other industry is in the same range as BHC (86). This means that SUPN’s stock grew similarly to BHC’s over the last 12 months.

BHC's P/E Growth Rating (97) in the Pharmaceuticals Other industry is in the same range as SUPN (100). This means that BHC’s stock grew similarly to SUPN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHCSUPN
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Bullish Trend 11 days ago
74%
Declines
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 23 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
62%
View a ticker or compare two or three
Ad is loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VFL10.350.10
+0.93%
abrdn National Municipal Income Fund
SAT24.580.08
+0.33%
Saratoga Investment Corp
EMCR29.11-0.59
-1.99%
Xtrackers EM CarbReduc&ClimtImprvs ETF
QSPT25.78-1.02
-3.80%
FT Vest Nasdaq-100® Buffer ETF Sep
BSVO18.20-1.52
-7.71%
EA Bridgeway Omni Small-Cap Value ETF

SUPN and

Correlation & Price change

A.I.dvisor tells us that SUPN and DVAX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SUPN and DVAX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SUPN
1D Price
Change %
SUPN100%
-1.01%
DVAX - SUPN
30%
Poorly correlated
-0.16%
SNDL - SUPN
27%
Poorly correlated
-1.39%
ACET - SUPN
27%
Poorly correlated
-7.32%
ESPR - SUPN
26%
Poorly correlated
-7.19%
MKKGY - SUPN
24%
Poorly correlated
-2.16%
More